MZMarza de Sousa Zaranza

Marza de Sousa Zaranza

*This is an algorithmically generated author record based on publicly available information.

Marza de Sousa Zaranza has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ELMO CPAP: an innovative type of ventilatory support for COVID-19-related acute respiratory distress syndrome

    by Andrea Mazza Beliero, Ana Paula Pires Lazaro, Marza de Sousa Zaranza, Giovanna Mazza Cruz Lima, Alvaro Rolim Guimaraes, Nilcyeli Linhares Aragao, Gdayllon Cavalcante Meneses, Marcelo Alcantara Holanda, Polianna Lemos Moura Moreira Albuquerque, Geraldo Bezerra da Silva Junior, et al.

    Objective: To assess whether the use of ELMO, a helmet for noninvasive ventilation created in Brazil, had a positive impact on the prognosis of patients with hypoxemic respiratory failure caused by severe COVID-19. Methods: This is a retrospective study of 50 critically ill COVID-19 patients. Epidemiological, clinical, and laboratory data were collected on ICU admission, as well as before, during, and after ELMO use. Patients were divided into two groups (success and failure) according to the outcome. Results: ELMO use improved oxygenation parameters such as Pao(2), Fio(2), and the Pao(2)/Fio(2) ratio, and this contributed to a gradual reduction in Fio 2, without an increase in CO2, as determined by arterial blood gas analysis. Patients in the success group had significantly longer survival (p < 0.001), as determined by the Kaplan-Meier analysis, less need for intubation (p < 0.001), fewer days of hospitalization, and a lower incidence of acute kidney injury in comparison with those in the failure group. Conclusions: The significant improvement in oxygenation parameters, the longer survival, as reflected by the reduced need for intubation and by the mortality rate, and the absence of acute kidney injury suggest that the ELMO CPAP system is a promising tool for treating ARDS and similar clinical conditions.


  • Syndecan-1 levels predict septic shock in critically ill patients with COVID-19

    by Nilcyeli Linhares Aragão, Marza de Sousa Zaranza, Gdayllon Cavalcante Meneses, Ana Paula Pires Lázaro, Álvaro Rolim Guimarães, Alice Maria Costa Martins, Natalia Linhares Ponte Aragão, Andrea Mazza Beliero, Geraldo Bezerra da Silva Júnior, Sandra Mara Brasileiro Mota, et al.

    Background: The clinical picture of coronavirus disease 2019 (COVID-19)-associated sepsis is similar to that of sepsis of other aetiologies. The present study aims to analyse the role of syndecan-1 (SDC-1) as a potential predictor of septic shock in critically ill patients with COVID-19. Methods: This is a prospective study of 86 critically ill patients due to COVID-19 infection. Patients were followed until day 28 of hospitalization. Vascular biomarkers, such as vascular cell adhesion protein-1, SDC-1, angiopoietin-1 and angiopoietin-2, were quantified upon admission and associated with the need for vasopressors in the first 7 d of hospitalization. Results: A total of 86 patients with COVID-19 (mean age 60±16 y; 51 men [59%]) were evaluated. Thirty-six (42%) patients died during hospitalization and 50 (58%) survived. The group receiving vasopressors had higher levels of D-dimer (2.46 ng/ml [interquartile range {IQR} 0.6–6.1] vs 1.01 ng/ml [IQR 0.62–2.6], p=0.019) and lactate dehydrogenase (929±382 U/l vs 766±312 U/l, p=0.048). The frequency of deaths during hospitalization was higher in the group that received vasoactive amines in the first 24 h in the intensive care unit (70% vs 30%, p=0.002). SDC-1 levels were independently associated with the need for vasoactive amines, and admission values >269 ng/ml (95% CI 0.524 to 0.758, p=0.024) were able to predict the need for vasopressors during the 7 d following admission. Conclusions: Syndecan-1 levels predict septic shock in critically ill patients with COVID-19.


  • Open Access

    Predictors of mortality in critically ill patients with COVID-19 and diabetes

    by A.P.P. Lázaro, M.S. Zaranza, G.C. Meneses, N.L. Aragão, M.V.P. Freire, Á.R. Guimarães, A.M. Beliero, M.M.P. Dantas, L.C. Forte, A.M.C. Martins, et al.

    The COVID-19 pandemic has challenged the entire world, and patients with diabetes mellitus (DM) have been particularly affected. We aimed to evaluate predictors of mortality during the first 30 days of hospitalization in critically ill patients with COVID-19 and comorbid DM. This prospective study included 110 critically ill patients admitted with COVID-19 infection. Thirty-two (29%) patients had a previous diagnosis of DM. Clinical variables, laboratory tests, and vascular biomarkers, such as VCAM-1, syndecan-1, ICAM-1, angiopoietin-1, and angiopoeitin-2, were evaluated after intensive care unit (ICU) admission. A comparison was made between patients with and without DM. No difference in mortality was observed between the groups (48.7 vs 46.9%, P=0.861). In the multivariate Cox regression analysis, VCAM-1 levels at ICU admission (HR: 1 [1-1.001], P<0.006) were associated with death in patients with DM. Among patients with DM, advanced age (HR 1.063 [1.031-1.096], P<0.001), increased Ang-2/Ang-1 ratio (HR: 4.515 [1.803-11.308] P=0.001), and need for dialysis (HR: 3.489 [1.409-8.642], P=0.007) were independent predictors of death. Higher levels of VCAM-1 in patients with DM was better at predicting death of patients with severe COVID-19 and comorbid DM, and their cut-off values were useful for stratifying patients with a worse prognosis. Vascular biomarkers VCAM-1 and Ang-2/Ang-1 ratio were predictors of death in patients with severe COVID-19 and comorbid DM and those without DM. Additionally, kidney injury was associated with an increased risk of death.


  • Open Access

    Critically ill COVID-19 patients in northeast Brazil: mortality predictors during the first and second waves including SAPS 3

    by Ana Paula Pires Lázaro, Polianna Lemos Moura Moreira Albuquerque, Gdayllon Cavalcante Meneses, Marza de Sousa Zaranza, Ana Beatriz Batista, Natalia Linhares Ponte Aragão, Andrea Mazza Beliero, Álvaro Rolim Guimarães, Alessandra Marjorye Maia Leitão, Marcelo Costa Freire de Carvalho, et al.

    Background: The Simplified Acute Physiology Score (SAPS) 3 is a reliable score to predict mortality. This study aims to investigate the predictive values of SAPS 3 and other clinical parameters for death in critically ill coronavirus disease 2019 (COVID-19) patients. Methods: This is a prospective study in a tertiary hospital for patients who required intensive care due to COVID-19 infection in northeast Brazil. Two distinct groups were constructed according to the epidemiological data: first wave and second wave. The severity of patients admitted was estimated using the SAPS 3 score. Results: A total of 767 patients were included: 290 were enrolled in the first wave and 477 in the second wave. Patients in the first wave had more comorbidities, were put on mechanical ventilation and required dialysis and vasopressors more frequently (p<0.05). During the second wave, non-invasive ventilation was more often required (p<0.05). In both periods, older patients and higher SAPS 3 scores on admission were associated with death (p<0.05). Non-invasive ventilation use showed a negative association with death only in the second wave period. In the first wave, the SAPS 3 score was more useful (area under the curve [AUC] 0.897) in predicting death in critically ill COVID-19 patients than in the second wave (AUC 0.810). Conclusion: The SAPS 3 showed very reliable predictive values for death during the waves of the COVID-19 pandemic, mostly together with kidney and pulmonary dysfunction.